Immunology News and Research

Latest Immunology News and Research

Producing virus-specific antibodies after COVID-19

In order to design effective vaccines for COVID-19, we need to understand our immune responses. News-Medical speaks to Professor Chen Dong to find out more.

21 May 2020

Study may help to improve diagnosis and treatment of allergies

Results from a study led by investigators at Massachusetts General Hospital may help to improve the diagnosis and treatment of allergies, pointing to a potential marker of these conditions and a new therapeutic strategy.

20 May 2020

Scientists develop novel flow cytometry technique to quantify protein production in T-cells

A team of scientists from Hollings Cancer Center at the Medical University of South Carolina (MUSC) has developed a novel flow cytometry technique that can, for the first-time, quantify protein production in T-cells.

20 May 2020

Immunologists propose possible molecular mechanism for the deadly respiratory syndrome

Research into how the SARS-CoV-2 virus induces death is suggesting potential treatments for its most destructive complications.

20 May 2020

Current antibody tests are good enough to inform decisions about public health, say experts

While it's too soon to use COVID-19 antibody testing to issue "immunity passports", antibody tests that are available today are good enough to inform decisions about public health and relaxing social distancing interventions, says an international group of infectious disease and public health experts in Science Immunology today.

20 May 2020

Report describes clinical characteristics and outcomes of children hospitalized with COVID-19

While most children infected with the novel coronavirus have mild symptoms, a subset requires hospitalization and a small number require intensive care.

20 May 2020

Study shows how normal RAS interacts with mutated RAS in living cells

Many cancer medications fail to effectively target the most commonly mutated cancer genes in humans, called RAS.

19 May 2020

People with Hepatitis D have up to three times the risk of developing fatal liver cancer

Of all the hepatitis viruses, D is the most poorly known. This small virus, which can only infect people already infected with Hepatitis B, has so far been little studied.

18 May 2020

Asthma linked to longer intubation time in younger COVID-19 patients

New data suggest that asthma is associated with longer time on ventilators for hospitalized younger patients with COVID-19.

18 May 2020

Roswell Park team proposes possible new strategy for treating pancreatic cancer

A possible new strategy for treating pancreatic cancer highlights the promise of collaboration between experts in both precision medicine and immunology.

18 May 2020

People infected with hepatitis D are more prone to hepatocellular carcinoma

Of all the hepatitis viruses, D is the most poorly known.This small virus, which can only infect people already infected with Hepatitis B, has so far been little studied.

18 May 2020

Boehringer Ingelheim acquires Northern Biologics to expand cancer immunology portfolio

Boehringer Ingelheim today announced the acquisition of Northern Biologics Inc., a wholly owned subsidiary of Northern LP. By acquiring this entity, which focuses on therapeutic antibodies targeting the tumor microenvironment, Boehringer Ingelheim is now positioned at the forefront of the stromal biology space - an emerging area in cancer immunology.

From Boehringer Ingelheim International GmbH 18 May 2020

Specific immune cells induced by vaccination are early indicators of vaccine efficacy

Ludwig-Maximilians-Universität in Munich researchers have shown that a specific class of immune cells in the blood induced by vaccination is an earlier indicator of vaccine efficacy than conventional tests for neutralizing antibodies.

15 May 2020

Antiviral drug can help accelerate recovery of COVID-19 patients, study shows

An international team of researchers led by Dr. Eleanor Fish, emerita scientist at the Toronto General Hospital Research Institute, University Health Network, and professor in the University of Toronto's Department of Immunology, has shown for the first time that an antiviral drug can help speed up the recovery of COVID-19 patients.

15 May 2020

First cellular immunology data to help guide social distancing recommendations

Scientists around the world are racing to develop a vaccine to protect against COVID-19 infection, and epidemiologists are trying to predict how the coronavirus pandemic will unfold until such a vaccine is available.

15 May 2020

Antiviral agent accelerates virus clearance in cases of COVID-19

A team of researchers from have found an antiviral therapy that seems to be an effective treatment for patients with moderate coronavirus disease 2019 (COVID-19).

15 May 2020

More cancer patients could benefit from CAR T-cell therapy, Moffitt study suggests

Chimeric antigen receptor T-cell therapy, or CAR T, has become a game changer for lymphoma and leukemia patients who have relapsed or become resistant to previous treatments.

14 May 2020

Rice engineer receives NSF grant to study effect of varying temperatures on coronavirus

Daniel Preston, an assistant professor of mechanical engineering at Rice's Brown School of Engineering, has received a National Science Foundation Rapid Response Research grant to study the effect of varying temperatures on the lifetime of the virus responsible for the COVID-19 pandemic.

14 May 2020

A promising treatment for chronic inflammatory liver disease

Primary sclerosing cholangitis (PSC) is a rare, chronic, inflammatory disease of the bile ducts and is difficult to treat.

14 May 2020

Visual Science designs a scientific model of SARS-Cov-2 virus

The biomedical visualization studio Visual Science has created the most detailed and scientifically accurate 3D model of the full SARS-CoV-2 virus at atomic resolution.

14 May 2020

Immunology News and Research

Latest Immunology News and Research

Producing virus-specific antibodies after COVID-19

Study may help to improve diagnosis and treatment of allergies

Scientists develop novel flow cytometry technique to quantify protein production in T-cells

Immunologists propose possible molecular mechanism for the deadly respiratory syndrome

Current antibody tests are good enough to inform decisions about public health, say experts

Report describes clinical characteristics and outcomes of children hospitalized with COVID-19

Study shows how normal RAS interacts with mutated RAS in living cells

People with Hepatitis D have up to three times the risk of developing fatal liver cancer

Asthma linked to longer intubation time in younger COVID-19 patients

Roswell Park team proposes possible new strategy for treating pancreatic cancer

People infected with hepatitis D are more prone to hepatocellular carcinoma

Boehringer Ingelheim acquires Northern Biologics to expand cancer immunology portfolio

Specific immune cells induced by vaccination are early indicators of vaccine efficacy

Antiviral drug can help accelerate recovery of COVID-19 patients, study shows

First cellular immunology data to help guide social distancing recommendations

Antiviral agent accelerates virus clearance in cases of COVID-19

More cancer patients could benefit from CAR T-cell therapy, Moffitt study suggests

Rice engineer receives NSF grant to study effect of varying temperatures on coronavirus

A promising treatment for chronic inflammatory liver disease

Visual Science designs a scientific model of SARS-Cov-2 virus

Immunology eBook

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production